Related Experiment Video
Updated: Jul 8, 2026
10:09
Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
Published on: February 14, 2012
A brain-specific decrease of the tyrosine hydroxylase protein in sepiapterin reductase-null mice--as a mouse model
Chisato Takazawa1, Kengo Fujimoto, Daigo Homma
1Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8501, Japan.
Biochemical and Biophysical Research Communications
|January 19, 2008
Summary
Sepiapterin reductase (SPR) deficiency causes severe monoamine deficits and tremors in mice, highlighting SPR's crucial role in tetrahydrobiopterin (BH4) synthesis and its potential link to Parkinson's disease (PARK3).
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Sepiapterin reductase (SPR) is key in tetrahydrobiopterin (BH4) biosynthesis.
- The human SPR gene is located within the PARK3 region, associated with familial Parkinson's disease.
Purpose of the Study:
- To investigate the role of SPR in BH4 metabolism.
- To analyze the phenotype and biochemical consequences of SPR deficiency.
Main Methods:
- Generation and analysis of Spr-deficient (Spr-null) mice.
- Measurement of BH4 levels.
- Assessment of monoamine levels and related protein expression (e.g., tyrosine hydroxylase).
Main Results:
- Spr-null mice showed significantly decreased BH4 levels.
- Homozygous mutants exhibited severe monoamine deficiencies and tremor phenotypes post-weaning.
- Tyrosine hydroxylase protein levels in the brain were drastically reduced (<10% of wild-type).
Conclusions:
- SPR is essential for adequate BH4 biosynthesis.
- SPR deficiency leads to neurological deficits, suggesting the SPR gene is a candidate for PARK3.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...